Keywords: novartis, deal, nih, signed, worldwide, licensing, agreement

Novartis In Deal With NIH

Article | 04 September 1997

Print This

- Novartis has signed an R&D and worldwide licensing agreement withthe US National Institutes of Health for an anti-CD3 immunotoxin, ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in